These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32589896)
21. SARS-CoV-2 related liver impairment - perception may not be the reality. Philips CA; Ahamed R; Augustine P J Hepatol; 2020 Oct; 73(4):991-992. PubMed ID: 32454042 [No Abstract] [Full Text] [Related]
22. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study. Singh S; Khan A Gastroenterology; 2020 Aug; 159(2):768-771.e3. PubMed ID: 32376408 [No Abstract] [Full Text] [Related]
23. Hematologic parameters in patients with COVID-19 infection: a reply. Fan BE Am J Hematol; 2020 Aug; 95(8):E215. PubMed ID: 32339335 [No Abstract] [Full Text] [Related]
24. Etiology and management of liver injury in patients with COVID-19. Yang RX; Zheng RD; Fan JG World J Gastroenterol; 2020 Aug; 26(32):4753-4762. PubMed ID: 32921955 [TBL] [Abstract][Full Text] [Related]
26. Treatments for COVID-19: emerging drugs against the coronavirus - reply. Potì F Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741 [No Abstract] [Full Text] [Related]
27. Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from authors. Galván-Casas C; Catalá A; Carretero Hernández G; Garcia-Doval I Br J Dermatol; 2020 Oct; 183(4):789. PubMed ID: 32569387 [No Abstract] [Full Text] [Related]
28. Bilirubin levels in patients with mild and severe Covid-19: A pooled analysis. Paliogiannis P; Zinellu A Liver Int; 2020 Jul; 40(7):1787-1788. PubMed ID: 32304343 [No Abstract] [Full Text] [Related]
29. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218 [TBL] [Abstract][Full Text] [Related]
30. COVID-19 and liver transplantation. Di Maira T; Berenguer M Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):526-528. PubMed ID: 32651555 [TBL] [Abstract][Full Text] [Related]
32. In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'. De Vriese AS; Reynders M Am J Kidney Dis; 2020 Oct; 76(4):598-599. PubMed ID: 32603712 [No Abstract] [Full Text] [Related]
33. REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19. Piaserico S; Meneguzzo A; Messina F J Infect; 2020 Sep; 81(3):e37-e38. PubMed ID: 32610110 [No Abstract] [Full Text] [Related]
34. Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends. Kannan S; Shaik Syed Ali Pakeer P; Sheeza Ali A; Hemalatha K Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6482-6483. PubMed ID: 32633333 [No Abstract] [Full Text] [Related]
36. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis. Wang H; Qiu P; Liu J; Wang F; Zhao Q Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):653-661. PubMed ID: 32418852 [TBL] [Abstract][Full Text] [Related]
38. Reply to Letter to the Editor "Comfort and compliance with the use of facemasks during COVID-19 infection". Haers PE; Swennen GRJ Int J Oral Maxillofac Surg; 2020 Nov; 49(11):1523-1524. PubMed ID: 32814656 [No Abstract] [Full Text] [Related]
39. Clinical characteristics of coronavirus disease 2019 patients complicated with liver injury. Wen M; Lu J; Xie Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):555-559. PubMed ID: 32879106 [TBL] [Abstract][Full Text] [Related]
40. Authors' Reply. Farkash EA; Wilson AM; Jentzen JM J Am Soc Nephrol; 2020 Sep; 31(9):2225-2226. PubMed ID: 32792369 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]